연구성과로 돌아가기
JCR 2023 저널 목록 (78 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seminars in Immunopathology | SPRINGER HEIDELBERG | 1863-2297 | 1863-2300 | SCIE | PATHOLOGY | 5,957 | 7.9 | Q1 | 4.0 | 96.0 | 4/88 | 10.5 | Q1 | 7.8 | 3.2 | 1.45 | 12/88 | Q1 | 86.93 | 0.007 | 1.446 | 2.890 | Q1 | 18 | 0.0% | 6.1 | 5.2 | 0 | 57.1% | 2025-03-24 17:35:28 | 바로가기 |
| Theranostics | IVYSPRING INT PUBL | 1838-7640 | 1838-7640 | SCIE | MEDICINE, RESEARCH & EXPERIMENTAL | 41,385 | 12.4 | Q1 | 4.0 | 96.0 | 8/189 | 12.0 | Q1 | 12.3 | 2.5 | 2.63 | 7/189 | Q1 | 96.56 | 0.058 | 12.772 | 2.499 | Q1 | 304 | 78.6% | 3.7 | 5.6 | 239 | 99.0% | 2025-03-24 17:29:54 | 바로가기 |
| Translational Neurodegeneration | BMC | 2047-9158 | 2047-9158 | SCIE | NEUROSCIENCES | 3,460 | 10.8 | Q1 | 4.0 | 96.0 | 13/310 | 11.6 | Q1 | 10.7 | 2.7 | 2.19 | 16/310 | Q1 | 95.00 | 0.005 | 1.052 | 2.768 | Q1 | 47 | 42.6% | 3.7 | 6.9 | 20 | 100.0% | 2025-03-24 17:32:18 | 바로가기 |
| TRENDS IN MICROBIOLOGY | CELL PRESS | 0966-842X | 1878-4380 | SCIE | MICROBIOLOGY | 18,276 | 14.0 | Q1 | 4.0 | 96.0 | 7/161 | 17.0 | Q1 | 13.9 | 5.1 | 1.53 | 18/161 | Q1 | 89.13 | 0.016 | 3.605 | 4.931 | Q1 | 77 | 3.9% | 7.6 | 5.7 | 3 | 23.5% | 2025-03-24 17:30:47 | 바로가기 |
| ACTA PHARMACOLOGICA SINICA | NATURE PUBL GROUP | 1671-4083 | 1745-7254 | SCIE | PHARMACOLOGY & PHARMACY | 15,931 | 6.9 | Q1 | 4.1 | 95.9 | 15/354 | 7.6 | Q1 | 6.8 | 1.1 | 1.43 | 28/354 | Q1 | 92.23 | 0.013 | 2.869 | 1.477 | Q1 | 156 | 91.0% | 5.8 | 6.1 | 142 | 13.5% | 2025-03-24 17:36:14 | 바로가기 |
| Acta Physiologica | WILEY | 1748-1708 | 1748-1716 | SCIE | PHYSIOLOGY | 6,059 | 5.6 | Q1 | 4.1 | 95.9 | 4/85 | 4.9 | Q1 | 4.2 | 2.0 | 1.62 | 6/85 | Q1 | 93.53 | 0.005 | 1.135 | 1.258 | Q1 | 89 | 58.4% | 6.8 | 8.8 | 52 | 46.4% | 2025-03-24 17:55:17 | 바로가기 |
| ADVANCED FUNCTIONAL MATERIALS | WILEY-V C H VERLAG GMBH | 1616-301X | 1616-3028 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 250,455 | 18.5 | Q1 | 4.1 | 95.9 | 10/231 | 19.6 | Q1 | 17.4 | 3.6 | 2.74 | 9/231 | Q1 | 96.32 | 0.308 | 67.643 | 4.049 | Q1 | 3523 | 90.7% | 3.6 | 4.2 | 3194 | 14.0% | 2025-03-24 16:59:21 | 바로가기 |
| Advances in Nonlinear Analysis | DE GRUYTER POLAND SP Z O O | 2191-9496 | 2191-950X | SCIE | MATHEMATICS, APPLIED | 1,193 | 3.2 | Q1 | 4.1 | 95.9 | 14/332 | 2.6 | Q1 | 3.0 | 1.8 | 3.38 | 2/332 | Q1 | 99.55 | 0.003 | 0.710 | 1.201 | Q1 | 86 | 100.0% | 3.0 | 13.1 | 86 | 97.4% | 2025-03-24 17:27:17 | 바로가기 |
| Anatomical Sciences Education | WILEY | 1935-9772 | 1935-9780 | SCIE | EDUCATION, SCIENTIFIC DISCIPLINES | 4,223 | 5.2 | Q1 | 4.1 | 95.9 | 4/86 | 5.7 | Q1 | 3.5 | 1.4 | 2.46 | 2/86 | Q1 | 98.26 | 0.003 | 0.649 | 0.982 | Q1 | 101 | 94.1% | 5.7 | 7.3 | 95 | 38.5% | 2025-03-24 17:07:04 | 바로가기 |
| ARCHIVES OF PHARMACAL RESEARCH | PHARMACEUTICAL SOC KOREA | 0253-6269 | 1976-3786 | SCIE | PHARMACOLOGY & PHARMACY | 8,495 | 6.9 | Q1 | 4.1 | 95.9 | 15/354 | 5.7 | Q1 | 6.4 | 1.8 | 1.26 | 49/354 | Q1 | 86.30 | 0.004 | 0.784 | 1.021 | Q1 | 56 | 58.9% | 10.0 | 5.9 | 33 | 10.3% | 2025-03-24 17:36:18 | 바로가기 |
| BIOMEDICINE & PHARMACOTHERAPY | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER | 0753-3322 | 1950-6007 | SCIE | PHARMACOLOGY & PHARMACY | 66,207 | 6.9 | Q1 | 4.1 | 95.9 | 15/354 | 6.8 | Q1 | 6.6 | 1.3 | 1.56 | 25/354 | Q1 | 93.08 | 0.072 | 15.714 | 1.141 | Q1 | 1743 | 67.6% | 4.0 | 5.8 | 1178 | 96.8% | 2025-03-24 17:36:09 | 바로가기 |
| BMJ Evidence-Based Medicine | BMJ PUBLISHING GROUP | 2515-446X | 2515-4478 | SCIE | MEDICINE, GENERAL & INTERNAL | 1,758 | 9.8 | Q1 | 4.1 | 95.9 | 14/329 | 9.5 | Q1 | 9.4 | 1.4 | 1.27 | 41/333 | Q1 | 87.84 | 0.005 | 1.097 | 3.613 | Q1 | 48 | 91.7% | 2.9 | 5.6 | 44 | 39.6% | 2025-03-24 17:29:28 | 바로가기 |
| BRIEFINGS IN BIOINFORMATICS | OXFORD UNIV PRESS | 1467-5463 | 1477-4054 | SCIE | BIOCHEMICAL RESEARCH METHODS | 21,557 | 6.8 | Q1 | 4.1 | 95.9 | 4/85 | 7.9 | Q1 | 6.3 | 1.2 | 1.99 | 3/85 | Q1 | 97.06 | 0.039 | 8.600 | 2.259 | Q1 | 507 | 88.2% | 2.8 | 6.1 | 447 | 24.8% | 2025-03-24 16:55:22 | 바로가기 |
| BUILDING AND ENVIRONMENT | PERGAMON-ELSEVIER SCIENCE LTD | 0360-1323 | 1873-684X | SCIE | ENGINEERING, CIVIL | 55,640 | 7.1 | Q1 | 4.1 | 95.9 | 8/182 | 7.2 | Q1 | 5.7 | 1.5 | 1.24 | 18/182 | Q1 | 90.38 | 0.036 | 8.013 | 1.085 | Q1 | 954 | 95.0% | 5.3 | 6.0 | 906 | 16.6% | 2025-03-24 17:08:48 | 바로가기 |
| CLINICAL ORAL IMPLANTS RESEARCH | WILEY | 0905-7161 | 1600-0501 | SCIE | DENTISTRY, ORAL SURGERY & MEDICINE | 15,754 | 4.8 | Q1 | 4.1 | 95.9 | 7/158 | 6.5 | Q1 | 4.1 | 0.8 | 1.47 | 18/158 | Q1 | 88.92 | 0.008 | 1.835 | 1.517 | Q1 | 161 | 91.9% | 9.7 | 6.6 | 148 | 38.4% | 2025-03-24 17:03:39 | 바로가기 |
페이지 이동: